---------------------- DOSAGE FORMS AND STRENGTHS-------------------

1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Gemzar safely and effectively. See full prescribing information for Gemzar. GEMZAR...

Gemcitabine: Gemzar®; Gemcitabine Ψ

Gemzar [package insert]. Indianapolis, IN; Eli Lilly and Company; May 2019. Accessed April 2024. 2. Gemcitabine [package insert]. Durham, NC; Accord Healthcare, Inc.; June 2019. Accessed...

Nutrition - Jacki Glew, Cheryl Sullivan, 2006

Google Scholar Gemzar [package insert]. Indianapolis, Ind: Eli Lilly and Company; 2004. Google Scholar The Block Comprehensive Health System: Your Guide to Healing. Evanston, Ill: Block...

Ramucirumab

^ Ramucirumab (Cyramza) package insert ^ Fuchs CS, Tomasek J, Yong CJ, Dumitru F, Passalacqua R, Goswami C, et al. (January 2014). "Ramucirumab monotherapy for previously treated advanced...

[논문]Phase I Study of GDC-0425, a Checkpoint Kinase 1 Inhibitor, in Combination w - 과학기술 지식인프라 ....

*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.

A Randomized, Open-Label, Safety and Exploratory Efficacy Study of Kanglaite Injection (KLTi) plus Gemcit....

Background: This study was designed to assess the safety and preliminary efficacy of KLTi plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer. Methods: In a randomized, open-label study, patients with locally advanced or metastatic pancreatic cancer were randomized 2:1 to receive KLTi plus gemcitabine or gemcitabine monotherapy. Three sequential cohorts were tested at 30 g/day, 50 g/day, and 30 g/day. Gemcitabine was administered at 1000 mg/m2 on days 1, 8 and 15 of each 28 day cycle. KLTi was administered on days ...

Duloxetine

Not to be confused with Dapoxetine or Dulcolax. Duloxetine Clinical data Trade names Cymbalta, Ariclaim, Yentreve, others [1] AHFS /Drugs.com Monograph MedlinePlus a604030 License data US...

Pharmacy Newsletter

Seoul National University Hospital Pharmacy Newsletter NOVEMBER 2023 Vol 43. No.11 CONTENTS 1.특집 기사 (1) 2023년 약제부 내 타부서 견학 보고서 23년 11월 약제부 소식 (2) 약학대학생 2023년 5차 필수실습소감문 II. 신약소개...

Home - electronic medicines compendium (emc)

The most up to date, comprehensive, regulated information about medicines. Easy to use, trusted and recommended by healthcare professionals

Phase I dose-escalation study of copanlisib in combination with gemcitabine or c

Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer R D Kim* ,1 , S R Alberts 2 , C Peña 3 , I...